Sugi Predict

Sugi Predict / Compounds / SCHEMBL250356

SCHEMBL250356

SCHEMBL250356

Cc1c(C)c2cccnc2c2ncccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 1.00
▸ HSP90AA1 P07900 2/20 1.00
▸ NPC1 O15118 1/20 1.00
▸ CCR1 P32246 6/20 0.57
▸ CCR8 P51685 6/20 0.57
▸ HTT P42858 2/20 0.52
▸ PSMD14 O00487 1/20 0.52
▸ COPS5 Q92905 1/20 0.52
▸ SLC6A2 P23975 1/20 0.52
▸ CCR5 P51681 4/20 0.50
▸ KDM4E B2RXH2 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ LMNA P02545 3/20 0.46
▸ GMNN O75496 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ MMP9 P14780 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL10480837 0.97 L3MBTL1 (0.95) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL30753478 0.97 L3MBTL1 (0.95) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL28307634 0.97 L3MBTL1 (0.95) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL31020232 0.97 L3MBTL1 (0.95) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL28554364 0.97 L3MBTL1 (0.95) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL21297741 0.91 L3MBTL1 (0.83) L3MBTL1HSP90AA1NPC1CCR1CCR8
Hydrochloric Acid SCHEMBL4591837 0.91 HSP90AA1 (0.83) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL15624642 0.90 L3MBTL1 (0.82) L3MBTL1HSP90AA1NPC1CCR1CCR8
Phenanthroline SCHEMBL20503157 0.89 L3MBTL1 (0.79) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL2681389 0.88 L3MBTL1 (0.78) L3MBTL1HSP90AA1NPC1CCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 734 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12605484-B2 Two-component system for the therapeutic treatment of skin lesions and production method thereof DTECH - SOCIETÀ A RESPONSABILITÀ LIMITATA (IT) 2026-04-21 — — US claimed
US-20250251347-A1 PORTABLE LIQUID ANALYZER VERITEQUE USA INC (US) 2025-08-07 — — US claimed
CN-119707711-A Methoxyna Ming's synthetic process 镇江中智化学科技有限公司 2025-03-28 — — CN claimed
CN-118513012-A All-solid-state polymer microparticles for extracting lithium from salt lake, preparation method thereof and lithium extraction method 青海大学 2024-08-20 — — CN claimed
CN-118389833-A Solvent extraction system for efficiently extracting and separating lithium 中国科学院过程工程研究所 2024-07-26 — — CN claimed
CN-117964579-A Method for preparing epoxypropane and co-producing carboxylic acid by propylene epoxidation 中山大学 2024-05-03 — — CN claimed
CN-117797810-A Selective hydrogenation catalyst, preparation method and application thereof 中国石油化工股份有限公司 2024-04-02 — — CN claimed
CN-117778055-A Hydrogen donor and application, recovery and regeneration method thereof 中国石油化工股份有限公司 2024-03-29 — — CN claimed
US-11940387-B2 Portable liquid analyzer VERITEQUE USA, INC. (US) 2024-03-26 — — US claimed
WO-2024020657-A1 METAL COMPLEX COMPOUNDS, A PROCESS FOR SYNTHESISING THE COMPOUNDS, POLYMERIC FILMS COMPRISING SAID COMPOUNDS AND USES OF SAME GS PARTNERS ADMINISTRAÇÃO E PARTICIPAÇÕES LTDA. (BR) 2024-02-01 — — WO claimed
US-4954414-A Photosensitive composition containing a transition metal coordination complex cation and a borate anion and photosensitive materials employing the same THE MEAD CORPORATION (US) 1990-09-04 — — US claimed
EP-0368629-A2 Photoinitiators and photosensitive compositions containing such photoinitiators THE MEAD CORPORATION (US) 1990-05-16 — — EP claimed
EP-0326835-A1 Porphyric insecticides The Board of Trustees for the University of Illinois (US) 1989-08-09 — — EP claimed
EP-0091383-B1 PROCESS FOR THE CATALYTIC REDUCTION OF NITRO-AROMATIC COMPOUNDS Montedison S.p.A. (IT) 1987-03-04 — — EP claimed
EP-0097592-B1 PROCESS FOR CATALYTICALLY REDUCING NITROAROMATIC COMPOUNDS Montedison S.p.A. (IT) 1986-12-10 — — EP claimed
US-4535162-A USING GROUP 8 METAL COORDINATION CATALYSTS MONTEDISON S.P.A. (IT) 1985-08-13 — — US claimed
EP-0097592-A2 Process for catalytically reducing nitroaromatic compounds Montedison S.p.A. (IT) 1984-01-04 — — EP claimed
US-4414417-A Process for the catalytic reduction of unsaturated ketones MONTEDISON, S.P.A. (IT) 1983-11-08 — — US claimed
EP-0091383-A1 Process for the catalytic reduction of nitro-aromatic compounds Montedison S.p.A. (IT) 1983-10-12 — — EP claimed
US-4290961-A Process for catalytically reducing carbonyl compounds MONTEDISON S.P.A. (IT) 1981-09-22 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605484-B2 Two-component system for the therapeutic treatment of skin lesions and production method thereof CUTA, CA2, ORAI1 L3MBTL1 3407/4885HSP90AA1 1489/4885NPC1 4194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.